Intervention

Antiandrogen

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions7

Lead sponsors shown3

Clinical trials

3 shown

Evolutionary Clinical Trial for Novel Biomarker-Driven TherapiesNCT07340541 · 2026-02-16

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14NCT03119857 · 2009-02-01

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate CancerNCT00283803 · 2002-03-12

Common conditions

Breast Cancer1 Estrogen-receptor-positive Breast Cancer1 Hormone Receptor Negative Breast Carcinoma1 Metastatic Breast Cancer1 Prostate Cancer1 Prostatic Neoplasms1 Triple Negative Breast Cancer1

Leading sponsors

Göteborg University1 UNC Lineberger Comprehensive Cancer Center1 University of Washington1

Trial status mix

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.